Historical Valuation
Labcorp Holdings Inc (LH) is now in the Fair zone, suggesting that its current forward PE ratio of 14.66 is considered Fairly compared with the five-year average of 14.64. The fair price of Labcorp Holdings Inc (LH) is between 239.74 to 289.18 according to relative valuation methord.
Relative Value
Fair Zone
239.74-289.18
Current Price：251.81
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Labcorp Holdings Inc (LH) has a current Price-to-Book (P/B) ratio of 2.40. Compared to its 3-year average P/B ratio of 2.31 , the current P/B ratio is approximately 4.00% higher. Relative to its 5-year average P/B ratio of 2.34, the current P/B ratio is about 2.55% higher. Labcorp Holdings Inc (LH) has a Forward Free Cash Flow (FCF) yield of approximately 6.62%. Compared to its 3-year average FCF yield of 5.39%, the current FCF yield is approximately 22.82% lower. Relative to its 5-year average FCF yield of 6.82% , the current FCF yield is about -2.99% lower.
P/B
Median3y
2.31
Median5y
2.34
FCF Yield
Median3y
5.39
Median5y
6.82
Competitors Valuation Multiple
AI Analysis for LH
The average P/S ratio for LH competitors is 3.09, providing a benchmark for relative valuation. Labcorp Holdings Inc Corp (LH.N) exhibits a P/S ratio of 1.44, which is -53.32% above the industry average. Given its robust revenue growth of 8.58%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for LH
1Y
3Y
5Y
Market capitalization of LH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of LH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is LH currently overvalued or undervalued?
Labcorp Holdings Inc (LH) is now in the Fair zone, suggesting that its current forward PE ratio of 14.66 is considered Fairly compared with the five-year average of 14.64. The fair price of Labcorp Holdings Inc (LH) is between 239.74 to 289.18 according to relative valuation methord.
What is Labcorp Holdings Inc (LH) fair value?
LH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Labcorp Holdings Inc (LH) is between 239.74 to 289.18 according to relative valuation methord.
How does LH's valuation metrics compare to the industry average?
The average P/S ratio for LH's competitors is 3.09, providing a benchmark for relative valuation. Labcorp Holdings Inc Corp (LH) exhibits a P/S ratio of 1.44, which is -53.32% above the industry average. Given its robust revenue growth of 8.58%, this premium appears unsustainable.
What is the current P/B ratio for Labcorp Holdings Inc (LH) as of Jan 10 2026?
As of Jan 10 2026, Labcorp Holdings Inc (LH) has a P/B ratio of 2.40. This indicates that the market values LH at 2.40 times its book value.
What is the current FCF Yield for Labcorp Holdings Inc (LH) as of Jan 10 2026?
As of Jan 10 2026, Labcorp Holdings Inc (LH) has a FCF Yield of 6.62%. This means that for every dollar of Labcorp Holdings Inc’s market capitalization, the company generates 6.62 cents in free cash flow.
What is the current Forward P/E ratio for Labcorp Holdings Inc (LH) as of Jan 10 2026?
As of Jan 10 2026, Labcorp Holdings Inc (LH) has a Forward P/E ratio of 14.66. This means the market is willing to pay $14.66 for every dollar of Labcorp Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Labcorp Holdings Inc (LH) as of Jan 10 2026?
As of Jan 10 2026, Labcorp Holdings Inc (LH) has a Forward P/S ratio of 1.44. This means the market is valuing LH at $1.44 for every dollar of expected revenue over the next 12 months.